# Pediatrix Medical Group Inc. (MD) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $27.03, market value $2.2 billion.

## Valuation
- **P/E (trailing): 12.9×** (5-yr avg 15.9×, 3-yr avg 11.0×). Pediatrix Medical Group Inc. trades at 12.9× trailing earnings, close to its own five-year average of 15.9×. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 11.1×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.04**. A PEG of 0.04 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.1×**. Each dollar of revenue is priced at 1.1×.
- **Price / book: 2.4×**. The shares trade at 2.4× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 10.1×**. Enterprise value is 10.1× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Earnings yield: 7.7%**. The inverse of the P/E: 7.7% of the price is earned each year.

## Profitability
- **Operating margin: 11.0%**. 11.0% of revenue is left after running the business.
- **Net margin: 8.6%**. 8.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 19.1%**. 19.1% on shareholders' equity is solid.
- **Return on invested capital: 15.6%**. Return on all capital, debt included, is 15.6%: comfortably above what that capital costs.
- **Return on assets: 7.8%**. Each dollar of assets produces 7.8% of profit.

## Growth
- **Revenue growth (1 yr): -4.9%** (3-yr -1.0%/yr, 5-yr 2.0%/yr). Revenue fell 4.9% over the last year, against 2.0% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 263.0%** (3-yr 34.9%/yr). Earnings per share rose 263.0%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.69**. Debt is 0.69 times equity, moderate leverage.
- **Net debt / EBITDA: 0.9×**. It would take 0.9 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 1.66** (quick 1.66). Current assets cover the next year's liabilities 1.66 times.
- **Altman Z-score: 2.82**. A Z-score of 2.82 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Pediatrix Medical Group Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 58.9%** (YTD 26.4%, 3-mo 19.5%). The shares are up 58.9% over twelve months including dividends.
- **From 52-week high: -3.3%** (72.2% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 57**. An RSI of 57 is neutral.
- **Beta (1 yr): 0.55** (volatility 42%). Beta of 0.55 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=MD · Page: https://foliofundamentals.com/stocks/md

Not investment advice.